Compounds > fusidic acid
Page last updated: 2024-09-04

fusidic acid and pyrazinamide

fusidic acid has been researched along with pyrazinamide in 4 studies

Compound Research Comparison

Studies
(fusidic acid)		Trials
(fusidic acid)		Recent Studies (post-2010)
(fusidic acid)		Studies
(pyrazinamide)		Trials
(pyrazinamide)		Recent Studies (post-2010) (pyrazinamide)
1,7421173443,6263201,113

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
de Jong, A; Hazenberg, HJ; Kuipers, EJ; Ploeger, B; Smit, FW1

Other Studies

4 other study(ies) available for fusidic acid and pyrazinamide

ArticleYear
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Nontuberculous mycobacterial sternal osteomyelitis in a patient without predisposing condition.
    The Netherlands journal of medicine, 1991, Volume: 38, Issue:3-4

    Topics: Adult; Chronic Disease; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pyrazinamide; Sternum

1991